Home
/ Ophirex
/ Competitors

Ophirex Competitors and Similar CompaniesClear all

Ophirex's competitors and similar companies include ECO Animal Health Group, LLOYD, 4P-Pharma and Dechra Pharmaceuticals.

	Ophirex Ophirex is a biotech company that provides oral treatment for snakebite envenoming.	ECO Animal Health Group ECO Animal Health Group is an animal health biotechnology company.	LLOYD LLOYD is a company that manufactures and markets nutritional and pharmaceutical products.	4P-Pharma 4P-Pharma is a biotech company specialized in the development of therapeutics for human and animal health.	Dechra Pharmaceuticals A growing global veterinary brand, providing the most appropriate therapeutic solutions and the best support to help you care for companion animals.
Founding Date	Founding Date 2015	Founding Date 1972	Founding Date 1958	Founding Date 2014	Founding Date 1997
Type	Type Private	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech drug development pharma veterinary	Tags Healthcare biotech drug development pharma veterinary	Tags Healthcare biotech drug development pharma veterinary	Tags Healthcare biotech drug development pharma veterinary	Tags Healthcare biotech drug development pharma veterinary
Locations	Locations Corte Madera, US HQ	Locations London, GB HQ Vinhedo, BR Huzhou, CN Dublin, IE Tokyo, JP Santiago De Querétaro, MX Urbandale, US	Locations Shenandoah, US HQ	Locations Lille, FR HQ Paris, FR	Locations Lostock Gralam, GB HQ Dornbirn, AT Pointe Claire, CA Uldum, DK Montigny Le Bretonneux, FR Aulendorf, DE Torino, IT see more
Employees	Employees 244% decrease	Employees 2241% decrease	Employees 95	Employees 307% increase	Employees 1,75336% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) £79.6m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) £761.5m (FY, 2023)
Cost of goods	Cost of goods N/A	Cost of goods £40.9m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods £176.4m (FY, 2023)
Gross profit	Gross profit N/A	Gross profit £39.1m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit £585.1m (FY, 2023)
Net income	Net income N/A	Net income £2.6m (FY, 2025)	Net income N/A	Net income N/A	Net income (£27.9m) (FY, 2023)